Effects of valsartan on cardiovascular events in patients with renal dysfunction
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Valsartan (Primary)
- Indications Coronary disorders
- Focus Therapeutic Use
- Acronyms V-CARD
- 26 Feb 2016 Biomarkers information updated
- 11 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Apr 2013 Planned end date changed from 1 Aug 2007 to 1 Dec 2016 as reported by ClinicalTrials.gov.